CRS Incorporated’s first priority is to keep our customers and potential customers fully apprised of the status of the claims brought by Frontline Placement.
As reported previously, CRS and Frontline entered into a license agreement in November of 2004 covering technology which included two issued Frontline patents. In exchange for royalty payments, Frontline granted CRS a world-wide, non-exclusive license with the right to grant sub-licenses, to make, use, import, offer to sell, or sell CRS’s licensed products and services. Since that time CRS has faithfully upheld its obligations under the terms of the agreement, including payment of all royalties due. Unfortunately, a controversy recently arose between CRS and Frontline regarding requested royalties on services and technologies not covered by the license agreement or the issued patents. Despite attempts on the part of CRS to resolve the controversy, Frontline wrongfully terminated the parties’ agreement.
On June 18, 2007, Frontline Placement filed a lawsuit alleging patent infringement by CRS. In response, CRS has filed an Answer and Counterclaims which denies the claims brought by Frontline, challenges the validity and enforceability of the Frontline patent-in-suit, and asserts counterclaims against Frontline for breach of contract. CRS has also requested a reexamination of the Frontline patent-in-suit by the United States Patent and Trademark Office.
CRS fully intends to act upon these claims in an aggressive manner. CRS takes pride in our substitute placement products and services, being one of first companies of its kind. We would like to reiterate that these claims will have no affect on our business and, more importantly, on the business of our Customers and Future Customers.
Please visit http://www.crs-ivr.com/pdf/AnswerCounterclaims.pdf to read the lawsuit.